N NEURONETICS INC
| Market Cap | $90.74M |
| P/E Ratio | — |
| Forward P/E | -2.79 |
| Dividend Yield | — |
| Beta | 0.94 |
| 52W Range | $1.17 - $5.34 |
| # Hedge Funds | 0 |
| Sector | Healthcare |
| Industry | Medical Devices |
Hedge Fund Ownership
| Investor 0 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|
Insider Trading
| Insider Name of the company insider who made the trade 19 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Jorey Chernett10% Owner | Buy | 385,442 | $1.25 | $481.80K | 30 Mar 2026 | 30 Mar 2026 |
| Jorey Chernett10% Owner | Buy | 500,000 | $1.35 | $675.00K | 27 Mar 2026 | 30 Mar 2026 |
| Chernett Jorey | Buy | 25,000 | $1.44 | $36.00K | 26 Mar 2026 | 25 Mar 2026 |
| Chernett Jorey | Buy | 125,000 | $1.40 | $175.00K | 25 Mar 2026 | 25 Mar 2026 |
| Chernett Jorey | Buy | 169,472 | $1.41 | $238.96K | 20 Mar 2026 | 20 Mar 2026 |
| MACAN WILLIAM ANDREWEVP, CLO and CS | Sale | 16,005 | $1.34 | $21.45K | 19 Mar 2026 | 19 Mar 2026 |
| Pfanstiel StevenEVP, CFO and Treasurer | Sale | 16,431 | $1.34 | $22.02K | 19 Mar 2026 | 19 Mar 2026 |
| Sullivan Keith J | Sale | 46,289 | $1.34 | $62.03K | 19 Mar 2026 | 19 Mar 2026 |
| Chernett Jorey | Buy | 450,000 | $1.33 | $598.50K | 19 Mar 2026 | 18 Mar 2026 |
| Chernett Jorey | Buy | 607,400 | $1.35 | $819.99K | 18 Mar 2026 | 18 Mar 2026 |
| Chernett Jorey | Buy | 531,000 | $1.16 | $615.96K | 17 Mar 2026 | 17 Mar 2026 |
| MACAN WILLIAM ANDREWEVP, CLO and CS | Sale | 609 | $1.34 | $816.06 | 04 Mar 2026 | 06 Mar 2026 |
| William Andrew MacanEVP, CLO and CS | Sale | 609 | $1.34 | $816.06 | 04 Mar 2026 | 06 Mar 2026 |
| Sullivan Keith JPresident and CEO | Sale | 8,452 | $1.35 | $11.41K | 26 Feb 2026 | 27 Feb 2026 |
| MACAN WILLIAM ANDREWEVP, CLO and CS | Sale | 3,427 | $1.35 | $4.63K | 26 Feb 2026 | 27 Feb 2026 |
| MACAN WILLIAM ANDREWEVP, CLO and CS | Sale | 14,120 | $1.65 | $23.30K | 12 Feb 2026 | 18 Feb 2026 |
| Sullivan Keith JPresident and CEO | Sale | 33,847 | $1.65 | $55.85K | 12 Feb 2026 | 18 Feb 2026 |
| MACAN WILLIAM ANDREWEVP, CLO and CS | Sale | 3,485 | $1.55 | $5.40K | 10 Feb 2026 | 12 Feb 2026 |
| Sullivan Keith JPresident and CEO | Sale | 40,976 | $1.55 | $63.51K | 10 Feb 2026 | 12 Feb 2026 |
Frequently Asked Questions
What is STIM stock price today?
NEURONETICS INC (STIM) is currently trading at $1.33. The stock has a 52-week range of $1.17 to $5.34 and a market capitalization of $90.74M.
Is STIM a good stock to buy in 2026?
NEURONETICS INC has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of -70.4%. 0 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling STIM stock?
There have been 19 insider transactions for STIM in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has STIM stock performed over the past year?
NEURONETICS INC (STIM) has returned -70.4% over the past 12 months. The stock traded between $1.17 and $5.34 during this period, and is currently at $1.33.
Which hedge funds own STIM (NEURONETICS INC)?
0 tracked hedge funds currently hold STIM in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is STIM's market cap and valuation?
NEURONETICS INC (STIM) has a market capitalization of $90.74M. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.
What is STIM's revenue and profitability?
NEURONETICS INC reported revenue of $129.87M with net income of N/A and a profit margin of N/A. The stock has a beta of 0.94.
What sector is STIM in and who are its biggest institutional holders?
NEURONETICS INC (STIM) operates in the Healthcare sector. It is held by 0 tracked hedge funds. See the ownership table above for the complete list.